Improved efficacy of pembrolizumab when combined with sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC
2024-07-22
(Press-News.org)
“Future development for sEphB4-HSA in HNSCC is likely to focus on patients with HPV-negative disease where there is greatest need to improve on the outcomes with pembrolizumab monotherapy.”
BUFFALO, NY- July 22, 2024 – A new research paper was published in Oncotarget's Volume 15 on July 10, 2024, entitled, “Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma.”
Patients with relapsed or metastatic head and neck squamous cell carcinoma (HNSCC) after primary local therapy have low response rates with cetuximab, systemic chemotherapy or check point inhibitor therapy. Novel combination therapies with the potential to improve outcomes for patients with HNSCC is an area of high unmet need.
In this new study, researchers Alexandra Jackovich, Barbara J. Gitlitz, Justin Wayne Wong Tiu-lim, Vinay Duddalwar, Kevin George King, Anthony B. El-Khoueiry, Jacob Stephen Thomas, Denice Tsao-Wei, David I. Quinn, Parkash S. Gill, and Jorge J. Nieva from Rutgers New Jersey Medical School and the University of Southern California conducted a phase II single-arm clinical trial of locally advanced or metastatic HNSCC patients treated with a combination of soluble EphB4-human serum albumin (sEphB4-HSA) fusion protein and pembrolizumab after platinum-based chemotherapy with up to 2 prior lines of treatment.
“sEphB4-HSA in combination with pembrolizumab has a safety profile similar to what has been observed previously with no overlapping toxicity.”
The primary endpoints were safety and tolerability and the primary efficacy endpoint was overall response rate (ORR). Secondary endpoints included progression free survival (PFS) and overall survival (OS). HPV status and EphrinB2 expression were evaluated for outcome.
Twenty-five patients were enrolled. Median follow up was 40.4 months (range 9.8 – 40.4). There were 6 responders (ORR 24%). There were 5 responders in the 11 HPV-negative and EphrinB2 positive patients, (ORR 45%) with 2 of these patients achieving a complete response (CR). The median PFS in HPV-negative/EphrinB2 positive patients was 3.2 months (95% CI 1.1, 7.3). Median OS in HPV-negative/EphrinB2 positive patients was 10.9 months (95% CI 2.0, 13.7). Hypertension, transaminitis and fatigue were the most common toxicities.
“The combination of sEphB4-HSA and pembrolizumab has a favorable toxicity profile and favorable activity particularly among HPV-negative EphrinB2 positive patients with HNSCC.”
Continue reading: DOI: https://doi.org/10.18632/oncotarget.28605
Correspondence to: Alexandra Jackovich, Jorge J. Nieva
Emails: atj41@njms.rutgers.edu, jorge.nieva@med.usc.edu
Keywords: EphrinB2, EphB4, HNSCC, pembrolizumab, HPV-negative
Click here to sign up for free Altmetric alerts about this article.
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
X, formerly Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Reddit
Spotify, and available wherever you listen to podcasts
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Street., Suite 1
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-07-22
Toronto, ON - The US Surgeon General recently recommended a warning label for social media platforms due to concerns about their impact on youth mental health. The Surgeon General’s Advisory on Social Media and Youth Mental Health highlighted potential links between social media use and poor sleep quality in youth. Considering these concerns, what specific actions can adolescents and parents take to improve sleep?
A new national study, published in the Journal of Adolescent Health, offers insights into screen habits linked with better sleep.
“Ensuring adolescents get enough sleep is vital, as it supports ...
2024-07-22
About The Study: In this randomized study, individuals who received a cash benefit had significantly fewer emergency department visits, including those related to behavioral health and substance use, fewer admissions to the hospital from the emergency department, and increased use of outpatient subspecialty care. Study results suggest that policies that seek to alleviate poverty by providing income support may have important benefits for health and access to care.
Corresponding Author: To contact the corresponding author, Sumit D. Agarwal, M.D., M.P.H., Ph.D., email sagarwal14@bwh.harvard.edu.
To access the embargoed study: Visit our For The Media ...
2024-07-22
Traditional epidemiological studies have identified numerous potential risk factors, but observational studies have struggled to establish causal links due to confounding factors and reverse causation. Theoretically avoiding confounding and reverse causation, Mendelian randomization (MR) infers causality, offering novel research perspectives and methods for investigating risk factors of intestinal diseases (Figure 1).
MR research on intestinal disease
Based on MR methodology, researchers have identified lifestyle factors, circulating nutrients, and obesity as being associated with the risk of ...
2024-07-22
Among the vastly different ways of tackling a disease, controlling the genetic expression of cells is undoubtedly one of the most powerful. Over the past few decades, scientists have come up with dozens of innovative strategies that involve using messenger RNA (mRNA) to ‘force’ cells to build specific proteins. These mRNA-based therapies have recently gained prominence as vaccines against infectious diseases like COVID-19. Additionally, they hold significant potential for treating cancer and genetic disorders.
Since mRNA itself is ...
2024-07-22
When people are having a conversation, they rapidly take turns speaking and sometimes even interrupt. Now, researchers who have collected the largest ever dataset of chimpanzee “conversations” have found that they communicate back and forth using gestures following the same rapid-fire pattern. The findings are reported on July 22 in the journal Current Biology.
“While human languages are incredibly diverse, a hallmark we all share is that our conversations are structured with fast-paced turns of just 200 milliseconds on average,” ...
2024-07-22
An international team of researchers, including a Northwestern University chemist, has discovered that metallic minerals on the deep-ocean floor produce oxygen — 13,000 feet below the surface.
The surprising discovery challenges long-held assumptions that only photosynthetic organisms, such as plants and algae, generate Earth’s oxygen. But the new finding shows there might be another way. It appears oxygen also can be produced at the seafloor — where no light can penetrate — to support the oxygen-breathing (aerobic) sea life living in complete darkness.
The ...
2024-07-22
About The Study: The results of this cohort study suggest that prenatal cannabis use was associated with several adverse maternal health outcomes during pregnancy. Continued research is needed to understand whether characteristics of prenatal cannabis use (e.g., dose, mode, and timing) moderate these associations.
Corresponding Author: To contact the corresponding author, Kelly C. Young-Wolff, Ph.D., M.P.H., email kelly.c.young-wolff@kp.org.
To access the embargoed study: Visit our For The Media ...
2024-07-22
About The Study: The findings of this study suggest that sexual and gender minority adults in the U.S. have a disproportionate prevalence of epilepsy. The reasons for this disparity are likely complex and may be associated with biological and psychosocial determinants of health unique to this population; as such, these individuals are in need of protected access to medical care.
Corresponding Author: To contact the corresponding author, Emily L. Johnson, M.D., M.P.H., email ejohns92@jhmi.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaneurol.2024.2243)
Editor’s ...
2024-07-22
About The Study: In this randomized clinical trial, overground robot-assisted gait training using a wearable robot significantly improved gross motor function and gait pattern. This new torque-assisted wearable exoskeletal robot, based on assist-as-needed control, may complement standard rehabilitation by providing adequate assistance and therapeutic support to children with cerebral palsy.
Corresponding Author: To contact the corresponding author, Min-Keun Song, M.D., Ph.D., email drsongmk@chonnam.ac.kr.
To access the embargoed study: Visit our ...
2024-07-22
What:
Sexual and gender minorities (SGM)—individuals who identify as gay, lesbian, bisexual, queer, transgender, non-binary, or gender-diverse—are twice as likely to report active epilepsy compared to non-SGM individuals, based on a National Institutes of Health (NIH) analysis of data from the population-based National Health Information Survey. “Active epilepsy” means a person has been diagnosed with epilepsy and has had more than one seizure in the past year or is currently taking anti-seizure medication.
This study suggests that epilepsy could be added to the growing ...
LAST 30 PRESS RELEASES:
[Press-News.org] Improved efficacy of pembrolizumab when combined with sEphB4-HSA in HPV-negative EphrinB2-positive HNSCC
